Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fumoleau

Showing results (31-40 of 152) with videos related to

Pageof 16
Sort By:
American Journal of Clinical Oncology|January 1, 1990
Association of bolus tetrahydropyranyl adriamycin and 120 hours continuous 5-fluorouracil infusion in patients with metastatic breast cancerB Chevallier, P Fumoleau, P Kerbrat, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase II study of a new vinca alkaloid derivative, S12363, in advanced breast cancerA Adenis, J M Pion, P Fumoleau, et al.
Breast Cancer Research and Treatment|January 1, 1995
Current status of Taxotere (docetaxel) as a new treatment in breast cancerP Fumoleau, B Chevallier, P Kerbrat, et al.
Expert Opinion on Investigational Drugs|July 2, 2005
Docetaxel: a new active agent in the therapy of metastatic breast cancerP Fumoleau, A D Seidman, M E Trudeau, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
The EORTC and drug development. European Organisation for Research and Treatment of CancerD Lacombe, P Fumoleau, H Zwierzina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumorsM Marty, P Fumoleau, A Adenis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-early clinical studies group (ECSG)C J Punt, P Fumoleau, B van de Walle, et al.
Bulletin Du Cancer|January 1, 1986
[Phase II trial of pepleomycin in metastatic cancer of the prostate]E Garcia-Giralt, F Guinet, P Pouillart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumorsJ L Misset, E Gamelin, M Campone, et al.
Annales De Chirurgie|January 1, 1995
[Intestinal endosalpingiosis. Apropos of 2 cases]J Le Borgne, M F Nomballais, P A Lehur, et al.
Pageof 16

Showing results (31-40 of 152) with videos related to

Sort By:
Pageof 16
American Journal of Clinical Oncology|January 1, 1990
Association of bolus tetrahydropyranyl adriamycin and 120 hours continuous 5-fluorouracil infusion in patients with metastatic breast cancerB Chevallier, P Fumoleau, P Kerbrat, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase II study of a new vinca alkaloid derivative, S12363, in advanced breast cancerA Adenis, J M Pion, P Fumoleau, et al.
Breast Cancer Research and Treatment|January 1, 1995
Current status of Taxotere (docetaxel) as a new treatment in breast cancerP Fumoleau, B Chevallier, P Kerbrat, et al.
Expert Opinion on Investigational Drugs|July 2, 2005
Docetaxel: a new active agent in the therapy of metastatic breast cancerP Fumoleau, A D Seidman, M E Trudeau, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
The EORTC and drug development. European Organisation for Research and Treatment of CancerD Lacombe, P Fumoleau, H Zwierzina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumorsM Marty, P Fumoleau, A Adenis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-early clinical studies group (ECSG)C J Punt, P Fumoleau, B van de Walle, et al.
Bulletin Du Cancer|January 1, 1986
[Phase II trial of pepleomycin in metastatic cancer of the prostate]E Garcia-Giralt, F Guinet, P Pouillart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumorsJ L Misset, E Gamelin, M Campone, et al.
Annales De Chirurgie|January 1, 1995
[Intestinal endosalpingiosis. Apropos of 2 cases]J Le Borgne, M F Nomballais, P A Lehur, et al.
Pageof 16